Abstract
The purpose of this study was to determine whether α-lipoic acid and fisetin have protective effects against cataract in a streptozotocin-induced experimental cataract model. Twenty-eight male BALB/C mice were made diabetic by the intraperitoneal administration of streptozotocin (200 mg/kg). Three weeks after induction of diabetes, mice were divided randomly into 4 groups in which each group contained 7 mice; fisetin-treated group (group 1), α-lipoic acid-treated group (group 2), fisetin placebo group (group 3), α-lipoic acid placebo group (group 4). Fisetin and α-lipoic acid were administered intraperitoneally weekly for 5 weeks. Cataract development was assessed at the end of 8 weeks by slit lamp examination, and cataract formation was graded using a scale. All groups developed at least grade 1 cataract formation. In the fisetin-treated group, the cataract stages were significantly lower than in the placebo group (p = 0.02). In the α-lipoic acid-treated group, the cataract stages were lower than in the placebo group but it did not reach to a significant value. Both fisetin and α-lipoic acid had a protective effect on cataract development in a streptozotocin-induced experimental cataract model. The protective effect of fisetin appears as though more effective than α-lipoic acid.
This is a preview of subscription content,
to check access.

References
Obrosova IG, Chung SS, Kador PF (2010) Diabetic cataracts: mechanisms and management. Diabetes Metab Res Rev 26:172–180
Bron AJ, Sparrow J, Brown NA, Harding JJ, Blakytny R (1993) The lens in diabetes. Eye 7:260–275
Lee AY, Chung SS (1999) Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 13:23–30
Ahmed N (2005) Advanced glycation end products—role in pathology of diabetic complications. Diabetes Res Clin Pract 67:3–21
Hegde KR, Varma SD (2005) Combination of glycemic and oxidative stress in lens: implications in augmentation of cataract formation in diabetes. Free Radic Res 39:513–517
Scott BC, Aruoma OI, Evans PJ et al (1994) Lipoic acid and dihydrolipoic acid as antioxidants. A critical evaluation. Free Rad Res 20:119–133
Bors W, Heller W, Michel C, Saran M (1990) Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 186:343–355
Majumdar S, Srirangam R (2010) Potential of the bioflavonoids in the prevention and treatment of ocular disorders. J Pharm Pharmaco 62:951–965
Kalt W, Hanneken A, Milbury P, Tremblay F (2010) Recent research on polyphenolics in vision and eye health. J Agric Food Chem 58:4001–4007
Hegde KR, Henein MG, Varma SD (2003) Establishment of the mouse as a model animal for the study of diabetic cataracts. Ophthalmic Res 35:12–18
Suryanarayana P, Krishnaswamy K, Reddy GB (2003) Effect of curcumin on galactose-induced cataractogenesis in rats. Mol Vis 9:223–230
Olofsson EM, Marklund SL, Behndig A (2009) Enhanced diabetes-induced cataract in copper−zinc superoxide dismutase-null mice. Invest Ophthalmol Vis Sci 50:2913–2918
Wolff SP, Dean RT (1987) Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem J 245:243–250
Kyselová Z, Garcia SJ, Gajdosíková A, Gajdosík A, Stefek M (2005) Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats. Physiol Res 54:49–56
Suzuki YJ, Tsuchiya M, Packer L (1992) Lipoate prevents glucose-induced protein modifications. Free Rad Res Commun 17:211–217
Kojima M, Sun L, Hata I, Sakamoto Y, Sasaki H, Sasaki K (2007) Efficacy of alpha-lipoic acid against diabetic cataract. Jpn J Ophthalmol 51:10–13
Maitra I, Serbinova E, Tritschler H, Packer L (1995) Alpha-Lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborns. Free Rad Biol Med 18:823–829
Ishige K, Schubert D, Sagara Y (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30:433–446
Yao K, Zhang L, Zhang Y, Ye P, Zhu N (2008) The flavonoid, fisetin, inhibits UV radiation-induced oxidative stress and the activation of NF-кB and MAPK signaling in human lens epithelial cells. Mol Vis 14:1865–1871
Matsuda H, Wang T, Managi H, Yoshikawa M (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 11:5317–5532
Matsuda H, Morikawa T, Toguchida I, Yoshikawa M (2002) Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem Pharm Bull 50:788–795
Van Heyningen R (1959) Formation of polyols by the lens of the with sugar cataracts. Nature 164:194–196
Varma SD, Kinoshita JH (1976) Inhibition of lens aldose reductase by flavonoids-their possible role in the prevention of diabetic cataract. Biochem Pharmacol 25:2505
El-Aguizy HK, Richards RD, Varma SD (1983) Sugar cataracts in mongolian gerbil (Meriones unguiculatus). Exp Eye Res 36:839–844
Conflict of interest
The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kan, E., Kiliçkan, E., Ayar, A. et al. Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice. Int Ophthalmol 35, 115–120 (2015). https://doi.org/10.1007/s10792-014-0029-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-014-0029-3